Whether you're struggling with weight loss or looking for an effective way to manage diabetes, our personalized treatment plans with Tirzepatide and Semaglutide are designed to deliver results
Thakur V, Rupar CA, Ramsay DA, Singh R, Fraser DD
Current guidelines from the European Society of Cardiology and American Diabetes Association strongly endorse GLP-1 receptor agonists with proven cardiovascular benefit for patients with established atherosclerotic cardiovascular disease
Intermediate phase (weeks 5-8) This is when body composition changes typically become noticeable
doi: 10.1016/j.nutres.2009.12.003 54
Interestingly, studies have shown that the antioxidant activity of this compound has a circadian rhythm, having antioxidant properties when it is in the dark but pro-oxidant properties when it is in the light (Zhou et al., 2021)